FIELD: medicine, pharmaceutics.SUBSTANCE: given invention refers to a compound of formula its stereoisomers, including R and S isomers, wherein: A represents N Y and Y represent O --- is absent R1 and R2 are identical or different, and independently represent hydrogen or C1-12 alkyl R3 represents hydrogen R4 represents heteroaryl which can be optionally substituted in any acceptable position by one or more substitutes Ra Z represents -(CH2)n-heteroaryl which can be optionally substituted in any acceptable position by one or more substitutes Ra T, U, V and W are identical or different, and independently represent hydrogen or halogen Ra is independently specified in hydrogen, halogen, C1-12 alkyl, C1-12 haloalkyl, -C(=Y)OR7, -(CH2)nYR7, each of which can be optionally substituted in any acceptable position by halogen R7 represents hydrogen or C1-12 alkyl m represents 1 m′ represents 0 n represents 1 wherein: the above heteroaryl is specified in 1,2,3-triazolyl, pyridinyl, 1-oxypyridinyl (pyridinyl-N-oxide), pyrazinyl, isoxazolyl, imidazo[1,2-α]pyrimidinyl, imidazo[1,2-α]pyrazinyl. The compounds of the given invention are applicable to prevent, relieve and/or treat bacterial infections in an individual. The bacterial infection is caused by the drug-resistant species Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-resistant species like Mycobacterium tuberculosis, as well as linezolid-resistant species Staphylococcus and Enterococcus.EFFECT: phenyloxazolidinone compounds as antimicrobial agents.12 cl, 8 tbl, 3 exДанное изобретение относится к соединению Формулы I, его стереоизомерам, включая R и S изомеры, где: ′А′ представляет собой N Y и Y′ представляют собой О ′---′ отсутствует R1 и R2 являются одинаковыми или различными и независимо представляют собой водород или С1-12 алкил R3 представляет собой водород R4 представляет собой гетероарил, который может быть факультативно замещенным в любом приемлемом положении одн
